Ra Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.95 M
- Company Age 21 Year, 7 Months
- Last Filing with ROC 31 Mar 2017
- Open Charges ₹ 1.50 Cr
- Revenue Growth %
- Profit Growth 4.05%
- Ebitda 30.73%
- Net Worth -0.07%
- Total Assets -0.02%
About Ra Biotech
Ra Biotech Private Limited (RBPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 June 2003 and has a history of 21 years and seven months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2017. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.95 M.
The company currently has active open charges totaling ₹1.50 Cr.
Rajeev Bajpai and Ajay Shekhawat serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24230MH2003PTC140924
-
Company No.
140924
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
16 Jun 2003
-
Date of AGM
30 Sep 2017
-
Date of Balance Sheet
31 Mar 2017
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Ra Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajeev Bajpai
|
Director | 16-Jun-2003 | Current |
|
Ajay Shekhawat
|
Director | 01-Apr-2009 | Current |
Financial Performance of Ra Biotech.
Ra Biotech Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 4.05% increase in profit. The company's net worth dipped by a decrease of 0.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ra Biotech?
In 2017, Ra Biotech had a promoter holding of 15.79% and a public holding of 84.21%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Wizard Biotech Pvt. Ltd.Rajeev Bajpai is a mutual person
Charges (Loans)
₹15.00 M
₹0
Charges Breakdown by Lending Institutions
- The Shamrao Vithal Co-Op. Bank Ltd. : 1.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Jan 2010 | The Shamrao Vithal Co-Op. Bank Ltd. | ₹1.50 Cr | Open |
How Many Employees Work at Ra Biotech?
Unlock and access historical data on people associated with Ra Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ra Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ra Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
